Olin Corporation (OLN) | The Buildout — AI Infrastructure

The Verdict

Olin makes chlorine, caustic soda and vinyls intermediates, epoxy resins, and ammunition through Winchester. Its chemicals are commodity inputs into industrial markets — housing and construction among them — rather than components sold into AI data centers. The one thread that touches the buildout is the formulated epoxy solutions portfolio, which management points at electronics, semiconductors and power generation. That exposure is not broken out in any disclosure, and Olin does not present itself as an AI company.

Earnings Beat

Olin reported Q2 2026 revenue of $1,741.9 million and a gross margin of 9.8%. Adjusted EBITDA was $191.3 million, in the upper half of the $160 million–$200 million range management had guided. The quarter absorbed a $40 million hit to adjusted EBITDA from an unplanned outage at Freeport, Texas, and still delivered the best epoxy results in more than three years. The net loss was $13.3 million, or $0.12 per diluted share.

Management tone: Across the two calls, management's tone shifted from describing a recovery to describing a normalization. On the Q1 2026 call they highlighted epoxy returning to profitability and guided Q2 adjusted EBITDA to $160M–$200M. On the Q2 2026 call they called that quarter's export price spike an anomaly, quantified the Freeport outage to the dollar, and stated the higher leverage expectation plainly. Cost-program language hardened — from clear line of sight on Beyond250 to increasingly confident it will exceed the $250 million target. They declined to give an annual EBITDA outlook and declined detail on the Chemours supply agreement.

Management Guidance

On the Q2 2026 call, management guided Q3 2026 adjusted EBITDA to $100 million to $200 million, with Chemicals adjusted EBITDA relatively flat sequentially, epoxy slightly lower than Q2 but still positive, and Winchester showing modest sequential improvement. That transcribed range brackets a possible sequential decline after the $191.3 million Q2 print; the sources flag a likely transcription error that would read $160 million to $200 million. For the full year, management guided capital spending of approximately $200 million, cash taxes in a range of a net refund of $20 million to a net payment of $20 million, and end-2026 leverage of approximately 4.5x. It narrowed 2026 Beyond250 savings to more than $100 million and said it expects to exceed its $250 million cumulative target by 2028.

Trajectory

Revenue has been roughly flat — trailing twelve-month revenue of $6,703 million — after a soft stretch: $1,713 million in Q3 2025, $1,665 million in Q4 2025 and $1,583 million in Q1 2026, then a 10% sequential rebound to $1,742 million in Q2 2026. Gross margin fell from 10.7% in Q3 2025 to 1.9% in Q4 2025, then recovered to 4.8% in Q1 2026 and 9.8% in Q2 2026. The code-computed signal reads revenue decelerating, with a trailing four-quarter average growth rate of 0.7%. Adjusted EBITDA went from $86.2 million in Q1 2026 to $191.3 million in Q2 despite a $40 million outage hit. Management attributes part of that lift to a conflict-driven export price spike it calls an anomaly.

The Model

The model projects FY+1 revenue of $6,805 million and EBITDA of $653 million, a 9.6% margin, and FY+2 revenue of $7,071.0 million and EBITDA of $778 million, an 11.0% margin. FY+1 EBITDA sits above the $413.8 million trailing-twelve-month EBITDA in the audited data, and FY+2 implies a further margin step-up. These are the model's projections; the material does not include company guidance at the annual EBITDA level, which management declined to provide.

Projections are the median of 5 independent model runs. The model’s revenue sits 3.5% below analyst consensus.

On the Q2 2026 call, management guided Q3 2026 adjusted EBITDA to $100 million to $200 million, with Chemicals adjusted EBITDA relatively flat sequentially, epoxy slightly lower than Q2 but still positive, and Winchester showing modest sequential improvement. That transcribed range brackets a possible sequential decline after the $191.3 million Q2 print; the sources flag a likely transcription error that would read $160 million to $200 million. For the full year, management guided capital spending of approximately $200 million, cash taxes in a range of a net refund of $20 million to a net payment of $20 million, and end-2026 leverage of approximately 4.5x. It narrowed 2026 Beyond250 savings to more than $100 million and said it expects to exceed its $250 million cumulative target by 2028.

What Could Go Right — and Wrong

Looking Ahead

Over the next 12 months the questions are operational and structural. Operationally, Olin has to land Q3 near its guided range, hold the Freeport VCM repairs so the $20 million Q3 impact reverses in Q4, and see the Q4 tightening it expects arrive against a competitor's plan to add supply. Structurally, the all-stock merger with Huntsman — approved by both shareholder bases on 2026-08-25, with the HSR waiting period expiring on 2026-09-11 — is expected to close in the first half of 2027, with pre-closing integration planning beginning in Q3 2026.

Financials

Annual Summary

Key Ratios (Trailing)

The Company

Olin makes chlorine, caustic soda and the vinyls intermediates EDC and VCM, epoxy resins, and ammunition through Winchester. Its segments are Chlor Alkali Products and Vinyls (54% of 2025 sales), Epoxy (20%) and Winchester (26%). Chlorine, caustic soda and hydrogen are co-produced by electrolysis of salt at a fixed ratio — 1.0 ton of chlorine to 1.1 tons of caustic soda and 0.03 tons of hydrogen — and a significant portion of chlorine is converted internally into vinyls intermediates. The result is a commodity chemical cycle with a defense-exposed ammunition arm: U.S. government sales were approximately 13% of 2025 sales.

Olin describes itself as a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition, and it says all three segments are capital-intensive manufacturing businesses. It operates named sites including the Freeport, Texas vinyls complex, and it has been repositioning capacity — the Guarulhos, Brazil epoxy plant closed and new Stade, Germany supply agreements replaced higher-cost production. Management puts U.S. natural gas at around $2.70 to $2.80, which it calls a sizable advantage for U.S. producers. Winchester's propellant is purchased predominantly from one of the largest U.S. propellant suppliers, a counterparty the 10-K does not name.

Business Segments

Competitive Landscape

Olin competes in commodity chemical markets where pricing is set by supply and demand rather than by product differentiation. In North American chlor alkali its named competitors are OxyChem — which Occidental sold to Berkshire Hathaway in January 2026 — Westlake Chemical, Formosa USA and Shintech. In epoxy they are Huntsman, Westlake, Kukdo Chemical and Kumho P&B Chemicals. Management points to capacity closures across Europe, the U.S., Latin America and Asia and says very little new capacity is coming online before the end of the decade, and it describes itself as the last integrated epoxy producer in Europe. Westlake, a competitor, warns that a competitor will add supply later this year and says it aims to run its own assets at 100% regardless.

Supply Chain

Olin sits at the base of the chemical chain. It turns salt, hydrocarbons and energy into chlorine and caustic soda, then converts much of the chlorine into vinyls intermediates and epoxy sold to industrial customers. It is also a large buyer of natural gas and electricity.